I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Rediti, M.
~ 0
results:
OpenAccess-fulltext X
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
Clinical management of first-line advanced triple-negative ..:
Rediti, M
;
Punie, K
;
de Azambuja, E
...
boreal:243846. , 2020
Link:
http://hdl.handle.net/20..
?
2
Characterizing CDK12-Mutated Prostate Cancers:
Rescigno, P
;
Gurel, B
;
Pereira, R
...
Clinical cancer research : an official journal of the American Association for Cancer Research, 2021, 27 (2), pp. 566 - 574. , 2020
Link:
https://repository.icr.a..
?
3
Clinical management of first-line advanced triple-negative ..:
Rediti, M
;
Punie, K
;
de Azambuja, E
...
boreal:243846. , 2020
Link:
http://hdl.handle.net/20..
?
4
Early Post-treatment Prostate-specific Antigen at 4 Weeks a..:
Rescigno, P
;
Dolling, D
;
Conteduca, V
...
European urology oncology, 2020, 3 (2), pp. 176 - 182. , 2020
Link:
https://repository.icr.a..
?
5
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 p..:
Incorvaia L
;
Fanale D
;
Badalamenti G
...
info:eu-repo/semantics/altIdentifier/wos/WOS:000588358600001. , 2020
Link:
http://hdl.handle.net/10..
?
6
Immunological and clinicopathological features predict HER2..:
Rediti, Mattia
;
Fernandez-Martinez, Aranzazu
;
Venet, David
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624889/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
7
Copy number aberration analysis to predict response to neoa..:
Venet, David
;
Rediti, Mattia
;
Maetens, Marion M
...
uri/info:doi/10.1158/1078-0432.CCR-21-1317. , 2021
Link:
http://hdl.handle.net/20..
?
8
Supplementary Figure S16 from Differential Benefit of Metro..:
Andrea Joaquin Garcia
;
Mattia Rediti
;
David Venet
...
doi:10.1158/1078-0432.24710696.v1. , 2023
Link:
https://doi.org/10.1158/..
?
9
Supplementary Figure S2 from Differential Benefit of Metron..:
Andrea Joaquin Garcia
;
Mattia Rediti
;
David Venet
...
doi:10.1158/1078-0432.24710693.v1. , 2023
Link:
https://doi.org/10.1158/..
?
10
Supplementary Figure S6 from Differential Benefit of Metron..:
Andrea Joaquin Garcia
;
Mattia Rediti
;
David Venet
...
doi:10.1158/1078-0432.24710681.v1. , 2023
Link:
https://doi.org/10.1158/..
?
11
Supplementary Figure S4 from Differential Benefit of Metron..:
Andrea Joaquin Garcia
;
Mattia Rediti
;
David Venet
...
doi:10.1158/1078-0432.24710687.v1. , 2023
Link:
https://doi.org/10.1158/..
?
12
Supplementary Table S2 from Differential Benefit of Metrono..:
Andrea Joaquin Garcia
;
Mattia Rediti
;
David Venet
...
doi:10.1158/1078-0432.24710666.v1. , 2023
Link:
https://doi.org/10.1158/..
?
13
Supplementary Table S7 from Differential Benefit of Metrono..:
Andrea Joaquin Garcia
;
Mattia Rediti
;
David Venet
...
doi:10.1158/1078-0432.24710648.v1. , 2023
Link:
https://doi.org/10.1158/..
?
14
Supplementary Figure S8 from Differential Benefit of Metron..:
Andrea Joaquin Garcia
;
Mattia Rediti
;
David Venet
...
doi:10.1158/1078-0432.24710675.v1. , 2023
Link:
https://doi.org/10.1158/..
?
15
Supplementary Figure S12 from Differential Benefit of Metro..:
Andrea Joaquin Garcia
;
Mattia Rediti
;
David Venet
...
doi:10.1158/1078-0432.24710708.v1. , 2023
Link:
https://doi.org/10.1158/..
1-15